• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    The Journal of Clinical Investigation

    The Journal of Clinical Investigation

    JournalISSN 0021-9738eISSN 1558-8238中科院 医学 1区

    年发文量

    研究主题

    论文(41740)

    排序
    1NewC/EBP-β-mediated Upregulation of CaV1.2 Calcium Channel Increases Arterial Constriction in Mice with Ibrutinib-Associated Hypertension
    Ludan Zhang,Shumin Yin,Wei Hou, Dan Yang, Yiyuan Jia, Yun Liu, Yan Wang, Sirui Zhao, Xiaoyan Gao, Xiaolin Sun, Xiao Lu,Jianyong Li,

    Ibrutinib, a Bruton's tyrosine kinase inhibitor, is indicated for treating chronic lymphocytic leukemia (CLL), but hypertension is a common cardiovascular adverse event. Previous studies have linked ibrutinib to cardiac events through dysregulated intracellular calcium handling, but the mechanisms underlying ibrutinib-associated hypertension remain largely unknown. Here, we followed up 225 CLL patients receiving ibrutinib or managed with watch-and-wait strategy, and identified ibrutinib as an independent risk factor for hypertension. In mice, ibrutinib elevated arterial blood pressure (BP) without structural remodeling of small arteries, and it potentiated K + -induced vasoconstriction. In vascular smooth muscle cells (VSMCs), ibrutinib upregulated Ca V 1.2 channel expression and function, as evidenced by enhanced Ca V 1.2 currents and K + -triggered-[Ca 2+ ] i elevation. Mechanistically, ibrutinib suppressed casein kinase 2 (CK2)-mediated HSP90β phosphorylation, and stabilized C/EBP-β, which bound to the promoter of Cacna1c gene and drove CaV1.2 transcription. Significantly, C/EBP-β knockdown attenuated ibrutinib-induced Ca V 1.2 hyperactivity and vasoconstriction. Collectively, these findings reveal a CK2-HSP90β-C/EBP-β-Ca V 1.2 signaling cascade through which ibrutinib enhances vascular Ca 2+ influx and vasoconstriction, thereby elevating arterial BP. Thus, this study nominates C/EBP-β as a therapeutic target for ibrutinib-associated hypertension.

    2026
    引用
    AI阅读
    加入学术空间
    2NewTranscriptional Regulation of NK Cell State by ELF4 Links Innate Immune Licensing to Kidney Fibrosis
    Shen Li,Hailong Hu, Zachary R. Lanzar,Xiangchen Gu,Elisa Cruz-Morales,Audrey C. Bochi-Layec,Andrea Sánchez‐Navarro,Jihwan Park,Rojesh Shrestha,Hongbo Liu, Aaron Joseph Donner,Lin Meei‐Hua,

    Fibrosis is a common outcome of chronic tissue injury, yet immune regulators that are conserved across species and translatable to human disease remain poorly defined. By integrating human kidney transcriptomes with multiple murine models of kidney fibrosis, we identified the ETS transcription factor ELF4 as a conserved, immune-enriched regulator associated with disease severity. ELF4 expression was highest in natural killer (NK) cells. Genetic deletion of Elf4 , including NK cell–specific ablation, attenuated experimental kidney injury, with reduced inflammation, fibrosis, and loss of renal function. Single-cell and functional analyses showed that ELF4 deficiency disrupts late-stage NK cell maturation and broadly suppresses cytotoxic and interferon-γ (IFNγ) effector programs. Mechanistically, ELF4 directly sustains STAT1 transcription, maintaining a STAT1–TBX21 program required for NK cell maturation and effector competence. Consistent with this framework, NK cell depletion, IFNγ neutralization, or antisense-mediated suppression of Elf4 phenocopied renal protection. Together, these findings identify ELF4 as a transcriptional licensing factor that links NK cell state to kidney injury and highlight innate immune programming as a potential therapeutic entry point in chronic kidney disease.

    2026
    引用
    AI阅读
    加入学术空间
    3NewPhase 2a Study of Readthrough Therapy in Nonsense Mutation Alport Syndrome
    Daniel Philip Gale,Detlef Böckenhauer,Maryline Fresquet, E. G. Williams, Conor J. Sugden,Melanie Chan,Katie Wong,Lin Meei‐Hua,Kohei Omachi, Konstantinos Tzoumkas, Lior Horonchik, Roger B. Clark,

    BACKGROUND. Alport syndrome (AS), a Mendelian kidney disease, is caused by pathogenic mutations in the X- linked gene COL4A5 and autosomal genes COL4A3 , COL4A4 encoding the alpha-chains secreted by podocytes to form the glomerular basement membrane collagen α3α4α5(IV) trimer. Nonsense mutations in autosomal recessive and hemizygous X-linked Alport syndrome (NMAS) introduce premature termination codons and have a particularly poor prognosis, with kidney failure typically occurring by early adulthood. There is substantial unmet need for effective therapy for AS, which has no approved treatments. Exaluren (formerly ELX-02) is a novel eukaryotic ribosome-targeted glycoside that is preferentially taken up by kidney cells and promotes readthrough of premature but not native termination codons, allowing full-length protein production. METHODS. In this proof-of-mechanism study, three patients (ages 12–18) with autosomal recessive Alport syndrome and a COL4A4 premature termination codon received daily subcutaneous exaluren (0.75 mg/kg) for 8 weeks. RESULTS. Safety and tolerability assessments (primary endpoint) revealed no new signals. Secondary endpoints assessed by kidney biopsy before and after treatment revealed increased collagen α3(IV), α4(IV) and α5(IV) abundance, physiologically localised collagen α5(IV), and partially improved podocyte morphology in all participants, with changes directionally concordant with increased collagen α3α4(IV) abundance. Proteinuria changes were inconsistent with interpretation limited by intra-patient variability and the short treatment duration; hematuria persisted in all participants. CONCLUSION. These findings provide first-in-human evidence of exaluren-mediated collagen IV readthrough and justify further trials in Alport syndrome and other nonsense mutation-driven kidney diseases, which often cause early-onset kidney failure. TRIAL REGISTRATION. ClinicalTrials.gov Identifier: NCT05448755.

    2026
    引用
    AI阅读
    加入学术空间
    4NewMicroglial GRB2 is Essential for Brain Ventriculogenesis and Cerebrospinal Fluid Homeostasis
    Phan Q. Duy,Benjamin C. Reeves,Huanxing Sun,Xueyan Peng,Pazhanichamy Kalailingam,Garrett Allington,Evan Dennis,Le Thi Hao, Lei Wang,David Rufino-Ramos,Shujuan Zhao, Qiang Li,

    Microglia play essential yet poorly understood roles in brain development, including axon guidance, regulation of neurogenesis, and pruning of neuronal projections. Congenital hydrocephalus (CH), characterized by enlarged ventricles filled with cerebrospinal fluid (CSF), is a leading cause of pediatric brain surgery, but its molecular mechanisms remain unclear. We have identified what we believe to be novel, recurrent, damaging missense variants in the SH3-binding domain of the adaptor protein growth factor receptor-bound protein 2 (GRB2) in unrelated patients with CH. GRB2 is significantly coexpressed with 1 of its known upstream RTK partners, CSF1R, in the developing human brain, particularly in a microglial subtype associated with regulation of neural stem cells. IPvalidated GRB2-CSF1R binding in mouse microglial cells and a human monocyte cell line. Cx3cr1-Grb2fl/fl mice engineered with conditional deletion of Grb2 in microglia exhibit congenital absence of microglia and early postnatal severe communicating (nonobstructive) hydrocephalus, mimicking the condition of patients with the GRB2 mutation. The severe ventriculomegaly of Cx3cr1-Grb2fl/fl mice is associated with both depletion of cerebral cortical neurons and impairment of glia-lymphatic-mediated CSF flow. Together, these findings implicate a role of GRB2 in microglia that could be essential for brain development and CSF homeostasis.

    2026
    引用
    AI阅读
    加入学术空间
    5NewHypothalamic-amygdala Gating of Caregiving-Like Behavior in Mice
    Kai-Wen Geng,Rui-Rui Wang, Yan Yang, Yan Wang,Ting He, Li, Chong-Shun Xu, Jun Chen

    Distress sharing within an ingroup instinctively motivates caregiving-like prosocial behavior in social animals and humans, yet how aversive social stimuli paradoxically trigger such behavior remains unclear. Here, we show that stress-state matching in observer mice elicits caregiving-like behaviors (allogrooming and injury-targeted allolicking) toward cagemates in pain, resulting in synchronized social buffering. Importantly, we identify that the excitation of vasopressin receptor 1a-expressing (V1aR-expressing) neurons in the central medial amygdala (CeM) underlies both emotional-state matching and subsequent allogrooming/allolicking. This excitation is accomplished by arginine vasopressin (AVP) release from presynaptic terminals of the hypothalamic paraventricular nucleus (PVN) to act specifically on postsynaptic V1aR in the CeM. The CeMV1aR neurons then project to the ventral tegmental area (VTA) to drive caregiving-like actions through positive reinforcement, manifested as prosocial preference and recurrent allogrooming/allolicking, and to produce anxiolysis in the caregiver. Collectively, we unravel a dedicated trisynaptic PVNAVP-CeMV1aR-VTA circuit driving and gating caregiving-like behaviors and advance the mechanistic understanding of AVP-V1aR signaling in prosociality.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 41740 篇论文

    高被引作者

    作者引用发文
    Gerald I Shulman2457459
    Raghu Kalluri2343620
    Joseph Goldstein1877439
    Jeffrey S. Flier1850826
    C. Ronald Kahn1809383
    Rudolph L. Leibel1805915
    Michael S. Diamond1762810
    Stuart P. Weisberg175144
    John Dye169693
    David Harrison1695730

    高产作者

    作者引用发文
    Ushma S. Neill47595
    C. Ronald Kahn1809383
    Gerald I Shulman2457459
    Alan R Tall1247756
    Ronald G. Crystal1175255
    Jerrold M. Olefsky1631147
    Floyd C. Rector574840
    Joseph Goldstein1877439
    Philip Felig1173839
    Joseph Witztum1677638

    相关期刊

    Immunity
    Gene expression
    Journal of Experimental Medicine
    Journal of translational medicine
    Science translational medicine
    JCI insight
    Signal transduction and targeted therapy
    Nature Reviews Immunology
    EBioMedicine
    International Immunopharmacology